We’re pushing the boundaries of neuroscience to transform the treatment of mental illness

We are a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. We pride ourselves on our deep expertise in neuroscience and inventive thinking around drug discovery and development. Since our inception, we have worked relentlessly to advance a pipeline of novel medicines with the goal of making a profound difference in the lives of those affected by these complex conditions.

andrew miller headshot
The unmet needs in neuroscience are endless, but ultimately, what we at Karuna have the chance to do is introduce a completely new option into the treatment paradigm for schizophrenia, and hopefully we can be a part of finding other products that have that similar type of potential."
- Andrew Miller, Founder & Chief Operating Officer

Executive team

Our executive team has deep expertise in neuroscience and is taking the helm in advancing the treatment of mental illness.

Board of directors

Scientific advisory board